THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER
- Unique Entity ID (UEI)
- S3GMKS8ELA16
- Parent company
- UNIVERSITY OF TEXAS SYSTEM (UEI X5NKD2NFF2V3)
- Registered address
- HOUSTON, TX, district TX-09
- Other names on record
- H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC.; M. D. ANDERSON CANCER CENTER; RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY; THE UNIVERISTY OF TEXAS MD ANDERSON CANCER CENTER A COMPONENT OF THE UNIVERISTY; THE UNIVERISTY OF TEXAS MD ANDERSON CANCER CENTER, A COMPONENT OF THE UNIVERISTY OF TEXAS SYSTEM; THE UNIVERSITY OF TEXAS M D AN; THE UNIVERSITY OF TEXAS M D ANDERSON CANCER CENTER; U OF TEXAS MD ANDERSON CTR; UNIV OF TEXAS SYS CANCER CTR M D ANDERSON HO; UNIV OF TEXAS SYS CANCER CTR, M D ANDERSON HO
Dollars are contract obligations in the fiscal year, as USAspending adds them up from each award's transactions. A contract's full value can be larger and run over several years. A figure below zero is money taken back from contracts signed earlier.
Source: USAspending.gov, the Treasury’s public record of federal spending. Our copy was saved November 17, 2026.
Which agencies pay this vendor, and where the work is done
Fiscal year 2027
USAspending lists no contract dollars for this vendor in fiscal year 2027 yet.
Fiscal year 2026: $13,724,535.38
| Agency | Contract dollars |
|---|---|
| Department of Health and Human Services | $13,335,242.88 |
| Department of Veterans Affairs | $389,292.50 |
| District where the work is done | Contract dollars |
|---|---|
| TX-09Al Green | $12,165,802.13 |
| TX-27Michael Cloud | $1,578,579 |
| TX-30Jasmine Crockett | $2,762.50 |
| MD-08Jamie Raskin | -$22,608.25 |
Largest awards
The largest contract awards with activity from October 1, 2025 to September 30, 2027, by each award's total amount over its whole life. 0 rows of the answer belong to related companies and are left out.
| Award | Agency | Where the work is done | Award total | Start |
|---|---|---|---|---|
| 75R60219C00004NATIONAL CORD BLOOD INVENTORY | Department of Health and Human ServicesHealth Resources and Services Administration | HOUSTON, TX-09 | $67,006,495.07 | Ends September 3, 2036 |
| 75N97021C00001OPERATION AND MAINTENANCE OF THE CHIMPANZEE CARE CENTER (CCC) | Department of Health and Human ServicesNational Institutes of Health | HOUSTON, TX-09 | $8,683,557.87 | Ends August 31, 2026 |
| 75N98026C00052OPERATION AND MAINTENANCE OF THE CHIMPANZEE CARE CENTER (CCC) | Department of Health and Human ServicesNational Institutes of Health | BASTROP, TX-27 | $1,578,579 | Ends August 31, 2027 |
| 75N91025F00001PROJECT TITLE: LOW-DOSE ERLOTINIB AND MESALAMINE FOR PREVENTION OF COLITIS-ASSOCIATED COLORECTAL CANCER (CAC) | Department of Health and Human ServicesNational Institutes of Health | HOUSTON, TX-09 | $1,324,125 | Ends March 24, 2028 |
| 75N91023F00001FURTHER DEVELOPMENT OF IPSC-BASED VACCINE FOR COLON CANCER PREVENTION | Department of Health and Human ServicesNational Institutes of Health | HOUSTON, TX-09 | $1,293,012 | Ends December 25, 2026 |
| 75N91023F00002TARGETING DKK1 WITH A DNA VACCINE TO PREVENT DEVELOPMENT OF MULTIPLE MYELOMA | Department of Health and Human ServicesNational Institutes of Health | HOUSTON, TX-09 | $1,249,115 | Ends October 25, 2026 |
| 36C24524P0903MED PHYSICS PEER REVIEW SERVICES | Department of Veterans Affairs | HOUSTON, TX-09 | $1,147,040 | Ends September 29, 2027 |
| 75N91022F00001PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS-- TARGETING THE PARP PATHWAY FOR THE PREVENTION OF BREAST CANCER | Department of Health and Human ServicesNational Institutes of Health | HOUSTON, TX-09 | $1,121,090 | Ends May 31, 2027 |
| 75N91022F00002TARGETING STAT3 TO PREVENT NON-SMALL CELL LUNG CANCER (NSCLC) IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) | Department of Health and Human ServicesNational Institutes of Health | HOUSTON, TX-09 | $1,097,981 | Ends June 14, 2026 |
| 75N91021F00002TARGETING STAT3 TO PREVENT COLORECTAL CANCER SECONDARY TO INFLAMMATORY BOWEL DISEASE | Department of Health and Human ServicesNational Institutes of Health | HOUSTON, TX-09 | $930,247 | Ends March 15, 2025 |
| 75F40126C00055BAA FY26C1FP7 MD ANDERSON ONCOLOGY CENTER FOR EXCELLENCE (OCE), EVALUATING BAYESIAN EFFECTIVE SAMPLE SIZE AND DECISION CRITERIA FOR PEDIATRIC AND RARE DISEASE TRIALS | Department of Health and Human ServicesFood and Drug Administration | HOUSTON, TX-09 | $752,304 | Ends September 29, 2028 |
| 75N91024F00002TIME-RESTRICTED FEEDING FOR PANCREATIC CANCER PREVENTION | Department of Health and Human ServicesNational Institutes of Health | HOUSTON, TX-09 | $551,730 | Ends December 19, 2026 |
| 75F40126P00275BORDETELLA-FREE BABOONS FOR PERTUSSIS INFECTION AND VACCINATION STUDIES | Department of Health and Human ServicesFood and Drug Administration | HOUSTON, TX-09 | $368,626.80 | Ends August 31, 2027 |
| 75F40126P00158BORDETELLA-FREE BABOON STUDY | Department of Health and Human ServicesFood and Drug Administration | HOUSTON, TX-09 | $206,191.80 | Ends August 9, 2027 |
| 75F40120P00519DURATION OF PERTUSSIS IMMUNITY IN BABOONS STUDY | Department of Health and Human ServicesFood and Drug Administration | HOUSTON, TX-09 | $202,649.54 | Ends March 31, 2023 |
| 75F40121P00534MERKELOMV-AP STUDY (BABOONS) | Department of Health and Human ServicesFood and Drug Administration | SILVER SPRING, MD-08 | $202,106.75 | Ends September 2, 2022 |
| 75F40123P00335CENTER FOR BIOLOGICS EVALUATION AND RESEARCH DURATION OF PERTUSSIS IMMUNITY IN BABOONS STUDY | Department of Health and Human ServicesFood and Drug Administration | HOUSTON, TX-09 | $150,051.99 | Ends February 28, 2025 |
| 36C25726P0378RATIFICATION FOR CALIBRATION SERVICES | Department of Veterans Affairs | DALLAS, TX-30 | $2,762.50 | Ends May 15, 2026 |
Subcontracts it reported
A prime contractor reports the subcontracts it gives under an award (first-tier subawards). These are the largest it reported under its three largest awards, from every year of each award.
No subcontract is reported under this vendor’s largest awards.
Lobbying reports and campaign receipts that name this vendor
A name is matched only when it is the same name under the exact-name rule: letters and numbers alike, "&" read as "and", a leading "the" and one closing legal form (Inc, LLC, Corp, Corporation, Co, LP, LLP) set aside. A near name is never a match. Each match says which name matched.
THE UNIVERSITY OF TEXAS SYSTEM: its page on this site
How it matched: parent company name, exact name, in our table of organizations named in lobbying reports.
Lobbying reports that name UNIVERSITY OF TEXAS SYSTEM
How it matched: parent company name, exact name: the name in the lobbying report as client.
| Registrant | Client | Amount for the whole quarter | Quarter | Filed | Report |
|---|---|---|---|---|---|
| THE UNIVERSITY OF TEXAS SYSTEM | THE UNIVERSITY OF TEXAS SYSTEM | $110,000reported as expenses | Third quarter of 2026 | Open the report |